首页> 外国专利> Methods for the treatment of a Living host who has an infection by the hepatitis C virus; composition for the treatment of hepatitis C infection; and Product Development for LAdministration of Combination Therapy for the treatment of hepatitis C infection.

Methods for the treatment of a Living host who has an infection by the hepatitis C virus; composition for the treatment of hepatitis C infection; and Product Development for LAdministration of Combination Therapy for the treatment of hepatitis C infection.

机译：治疗被丙型肝炎病毒感染的活宿主的方法;用于治疗丙型肝炎感染的组合物;联合疗法治疗丙型肝炎感染的研究和产品开发。

页面导航

摘要
著录项
相似文献

摘要

Combination therapy methods for the treatment of hepatitis C virus infection and associated diseases, by the co-administration of 5-cyclopropyl-2-(4-fluoro-phenyl)-6-[(2-hydroxy-ethyl)-methanesulfonyl-amino]-benzofuran-3-carboxylic acid methylamide or a pharmaceutically acceptable salt thereof with natural, recombinant or modified interferon, that effectively inhibit viral replication.

机译：5-环丙基-2-（4-氟-苯基）-6-[[（2-羟基-乙基）-甲磺酰基-氨基]并用治疗丙型肝炎病毒感染及相关疾病的联合治疗方法-苯并呋喃-3-羧酸甲酰胺或其药学上可接受的盐与天然，重组或修饰的干扰素的结合，可有效抑制病毒复制。

著录项

公开/公告号CL2007002490A1

专利类型
公开/公告日2008-03-07

原文格式PDF
申请/专利权人 WYETH;VIROPHARMA INCORPORATED;
展开▼

申请/专利号CL20070002490
发明设计人 HOWE ANITA Y.M.;VILLANO STEPHEN.;
展开▼

申请日2007-08-24
分类号A61K31/192;A61K31/195;A61K38/21;A61P31/14;
国家 CL
入库时间 2022-08-21 20:08:35

相似文献

专利
外文文献
中文文献